Will Safety Issues Derail Denosumab? FDA Sets Advisory Cmte. Slot
This article was originally published in The Pink Sheet Daily
Executive Summary
Amgen’s much-ballyhooed monoclonal antibody, now called Prolia, faces safety questions at the Aug. 13 Advisory Committee for Reproductive Health Drugs meeting.